FSNUY Fresenius SE & Co. KGaA

$13.70

Fresenius SE & Co. KGaA (FSNUY) is expected to report earnings on November 4, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of +0.7% since its last earnings release on August 5, 2026.

Fresenius SE & Co. KGaA Missed Consensus Estimates
Wednesday, August 5, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.71

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Fresenius SE & Co. KGaA

Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.

Sector

Healthcare

Industry

Home Health Care